Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Hertzel C Gerstein,Helen M Colhoun,Gilles R Dagenais,Rafael Diaz,Mark Lakshmanan,Prem Pais,Jeffrey Probstfield,Jeffrey S Riesmeyer,Matthew C Riddle,Lars Rydén,Denis Xavier,Charles Messan Atisso,Leanne Dyal,Stephanie Hall,Purnima Rao-Melacini,Gloria Wong,Alvaro Avezum,Jan Basile,Namsik Chung,Ignacio Conget,William C Cushman,Edward Franek,Nicolae Hancu,Markolf Hanefeld,Shaun Holt,Petr Jansky,Matyas Keltai,Fernando Lanas,Lawrence A Leiter,Patricio Lopez-Jaramillo,Ernesto German Cardona Munoz,Valdis Pirags,Nana Pogosova,Peter J Raubenheimer,Jonathan E Shaw, Wayne H-H Sheu,Theodora Temelkova-Kurktschiev The Lancet(2019)
AI 理解论文
溯源树
样例